Could your weight actually speed up Alzheimer’s disease? That’s the surprising—and unsettling—question raised by a groundbreaking new five-year study that connected obesity with faster biological signs of Alzheimer’s progression. And here’s where it gets even more intriguing: the changes were detected not through brain scans alone but through simple blood tests tracking key biomarkers.
Researchers followed 407 participants enrolled in the Alzheimer’s Disease Neuroimaging Initiative, comparing those with and without obesity. Over time, individuals with obesity showed a 29% to 95% faster increase in Alzheimer’s-related blood biomarkers, including pTau217 and neurofilament light chain (NfL). Imaging also revealed a 3.7% faster buildup of amyloid plaques in their brains, alongside a 24% sharper spike in plasma NfL. These findings were unveiled at the Radiological Society of North America’s (RSNA) annual meeting in Chicago, marking the first study to tie obesity directly to Alzheimer’s disease using blood-based measures.
Dr. Cyrus Raji, senior author and principal investigator from Washington University’s Mallinckrodt Institute of Radiology, described it best: “For the first time, we’ve demonstrated a measurable link between obesity and Alzheimer’s disease using blood biomarkers.” The research team used amyloid PET imaging and plasma assays to monitor biomarkers like pTau217, GFAP, and NfL across multiple samples taken over five years. This long-term approach allowed them to trace how obesity shaped the biological trajectory of the disease, painting a clearer picture of its accelerating effect.
At the study’s baseline, things looked deceptively benign. People with a higher body mass index (BMI) actually seemed to have lower Alzheimer’s biomarker levels—a correlation that could trick researchers into misreading the data. “It’s not that obesity lowers Alzheimer’s pathology,” explained lead author Dr. Soheil Mohammadi. “Rather, the biomarkers appear diluted due to increased blood volume.” This insight highlights why long-term tracking matters—short-term snapshots can give a dangerously incomplete view of the disease.
As the years went by, though, the divergence became impossible to ignore. Participants with obesity showed dramatically steeper rises in blood biomarkers—up to nearly double that of their leaner counterparts. These biomarker surges aligned closely with growing amyloid deposits seen on PET scans. Yet one finding shocked even the researchers: blood tests appeared more sensitive than PET scans at detecting obesity’s influence on disease progression. “That sensitivity was the biggest surprise of all,” said Raji.
The implications go far beyond academic curiosity. Mohammadi pointed to the 2024 Lancet Commission report, which lists 14 modifiable risk factors responsible for roughly 45% of Alzheimer’s risk—nearly half of all cases. Weight is one of the most promising to tackle. If obesity accelerates Alzheimer’s pathology, then lifestyle changes or new anti-obesity drugs could potentially slow the disease before symptoms appear. “Every risk factor we reduce buys time,” Mohammadi emphasized.
Looking ahead, Raji envisions a future where routine blood tests help physicians track Alzheimer’s risk and evaluate treatments much earlier than we can today. “We’re entering a new era,” he noted. “Now that we have effective obesity treatments, we can examine whether weight loss actually improves these Alzheimer’s biomarkers. That’s extraordinary.” He added that combining these blood tests with MRI scans could give clinicians a powerful double lens for monitoring the brain’s response to interventions.
It’s a provocative finding—and one likely to stir debate. Some may argue that obesity’s link to Alzheimer’s reflects overall metabolic stress rather than a direct cause-and-effect relationship. Others might suggest it’s another reason to view obesity not just as a lifestyle issue, but as a neurological risk factor. What do you think? Should Alzheimer’s prevention start with tackling obesity more aggressively, or are there deeper biological forces at play? Share your thoughts in the comments below.
Source: Blood test shows obesity speeds Alzheimer’s development. Radiological Society of North America, December 2, 2025. https://prnmedia.prnewswire.com/news-releases/blood-test-shows-obesity-speeds-alzheimers-development-302627268.html
Stay informed with the Patient Care Newsletter, your go-to source for evidence-based clinical updates, diagnostics, and treatment strategies designed to strengthen everyday medical decision-making.
